Pharmaceutical

IBA venture PanTera gains €134m in funding to scale up actinium-225 production

The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.

Sep 12, 2024 - 04:00
IBA venture PanTera gains €134m in funding to scale up actinium-225 production
The IBA-SCK CEN joint venture secured funds to increase production of the radioisotope used in cancer therapies.
Read the original article

Tags:

Previous Article

EASD 2024: Are tetra-agonists the future of metabolic diseases treatment?

Next Article

EASD 2024: Novo Nordisk’s Saxenda shows weight loss in children

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: FDA slams company recalling eye drops over manufacturing issues; U.S. funds massive Alzheimer’s research database

STAT+: Pharmalittle: FDA slams company recalling eye dr...

Apr 3, 2023

Boehringer and Lilly gain FDA approval for kidney disease therapy

Boehringer and Lilly gain FDA approval for kidney disea...

Sep 25, 2023

Some hoped a new oral vaccine would solve all the polio campaign’s problems. Reality is settling in

Some hoped a new oral vaccine would solve all the polio...

May 27, 2023